Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Rivaroxaban 15 mg tablets under fed conditions in healthy Thai volunteers
TCTR20221018002Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rivaroxaban (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
rivaroxaban
Beyond the preview
Go deeper on TCTR20221018002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221018002.